Table 2 Demographics of study participants
From: A high-throughput test enables specific detection of hepatocellular carcinoma
| Â | N | Age | Sex | Alcohol | Smoking | AFP | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | Significance | Male/Female | Significance | Fraction users | Significance | Fraction users | Significance | N | Mean ± St error | ||
Control | 49 | 26.14 |  | 42/7 | 0.99 | 0.2 |  | 0.32 |  | 1 | 1.02 + /− NA |
CHB | 51 | 28.71 | 0.99 | 42/9 | 0.99 | 0.21 | 0.99 | 0.35 | 0.99 | 22 | 2.2 + /− 0.9 |
HCC 0 | 2 | 62 | NA | 2/0 | 0.99 | NA | NA | NA | NA | 2 | 1387.4 + /− 866.4 |
HCC A | 32 | 49.15 | <0.0002 | 27/5 | 0.99 | 0.088 | 0.35 | 0.64 | 0.02 | 30 | 6460.5 + /− 12192.3 |
HCC B | 86 | 49.12 | <0.0003 | 72/14 | 0.99 | 0.069 | 0.047 | 0.52 | 0.13 | 79 | 17246.3 + /− 44977.5 |
HCC C | 106 | 49.34 | <0.0004 | 85/21 | 0.99 | 0.037 | 0.0047 | 0.54 | 0.05 | 100 | 11968.4 + /− 31972.1 |
HCC D | 76 | 52.45 | <0.0005 | 64/12 | 0.99 | 0.064 | 0.042 | 0.66 | 0.001 | 71 | 29499.9 + /− 67562.3 |
NON-HCC Cancers | 102 | 47.14 | NA | 48/54 | NA | 0.02 | NA | 0.39 | NA | NA | NA |
Healthy Plasma (InnovativeTM Research) | 50 | 38.1 | NA | 50/0 | NA | NA | NA | NA | NA | NA | NA |
